[MitraClip® for treatment of tricuspid valve insufficiency]. / MitraClip® zur Therapie der Trikuspidalinsuffizienz.
Herz
; 42(7): 644-650, 2017 Nov.
Article
em De
| MEDLINE
| ID: mdl-28791435
ABSTRACT
Tricuspid valve regurgitation is frequently found as a result of right ventricular remodeling due to advanced left heart diseases. Drug treatment is limited to diuretics and the cardiac or pulmonary comorbidities. Due to the high risk only a small percentage of patients are amenable to surgical treatment of tricuspid regurgitation in those who undergo left-sided surgery for other reasons. Catheter-based procedures are an attractive treatment alternative, particularly since the strong prognostic impact of tricuspid regurgitation suggests an unmet need of treatment, independent of the underlying heart disease. A vast amount of clinical experience exists for the MitraClip system for treatment of mitral regurgitation. A first case series shows that the application for treatment of tricuspid regurgitation is technically feasible, seems to be safe and the degree of valve regurgitation can be reduced. In this review the background of tricuspid regurgitation treatment is summarized and first experiences and perspectives with the MitraClip system are assessed.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Instrumentos Cirúrgicos
/
Insuficiência da Valva Tricúspide
/
Cateterismo Cardíaco
/
Anuloplastia da Valva Cardíaca
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
De
Revista:
Herz
Ano de publicação:
2017
Tipo de documento:
Article